- Supported exchanges /
- F /
- 4TO.F
MAINZ BIOMED B.V. EO 1 (4TO F) stock market data APIs
€0.226
0.01(4.5%)
as of October 29, 2024
Price chart is built with Anychart
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.
MAINZ BIOMED B.V. EO 1 Financial Data Overview
| 0.22 | |
| 0.226 | |
| - | |
| 0.24 | |
| 0.22 | |
| 0.15-3.145 | |
| 6 619 K | |
| 25 587 K | |
| 917 K | |
| 0.088 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'4TO',
Type:
'Common Stock',
Name:
'MAINZ BIOMED B.V. EO 1',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'NL0015000LC2',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Diagnostics & Research',
}
MAINZ BIOMED B.V. EO 1 Fundamental Data is available in our Financial Data APIs
- Net Revenue 917 K
- EBITDA -21 590 572
- Earnings Per Share -1.03
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get MAINZ BIOMED B.V. EO 1 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get MAINZ BIOMED B.V. EO 1 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
